Case guide

UPDATED FEB 2026

Talcum Powder & Asbestos Contamination

Part of the Talcum Powder investigation

The short answer

Asbestos contamination in J&J’s talcum powder products is a central pillar of the litigation. Talc and asbestos co-occur naturally in geological deposits, and J&J’s internal documents show the company knew its talc supply was contaminated since the 1970s.

The FDA confirmed asbestos in Baby Powder in 2019. Asbestos is a Group 1 carcinogen with no safe level of exposure — its presence in a product marketed for daily intimate use represents a catastrophic product safety failure.

People's Justice Research TeamUpdated February 20, 2026Fact-checked

Verified against court and regulatory records · No upfront fees · Your information is never sold

Free Case Review

Check your eligibility — free

Answer 2-3 quick questions to review your potential case.

Free · Confidential · About 2 minutes · A case specialist responds within 1 business day

Your answers are never sold or shared without your consent.

How Asbestos Contaminated Baby Powder

Talc and asbestos are both naturally occurring silicate minerals found in geological formations worldwide. They frequently co-occur in the same mineral deposits, meaning talc mining operations routinely encounter asbestos fibers — primarily tremolite, anthophyllite, and chrysotile. Without rigorous testing protocols and purification processes, these microscopic asbestos fibers become embedded in the talc that is processed into consumer products.

Johnson & Johnson’s talc was sourced from mining operations where asbestos was present in the surrounding geological formations. Internal J&J documents from the 1970s — obtained through litigation discovery and later unsealed — show that the company’s own testing detected asbestos fibers in talc samples destined for Baby Powder production. Rather than implementing more rigorous purification, sourcing talc from asbestos-free deposits, switching to alternative ingredients, or warning consumers, J&J chose to continue selling Baby Powder as "pure" and "safe."

The FDA’s October 2019 finding of chrysotile asbestos in commercially available J&J Baby Powder confirmed what plaintiffs had been arguing for years. This was the first independent federal regulatory confirmation of asbestos contamination in J&J’s flagship product. J&J voluntarily recalled approximately 33,000 bottles but initially disputed the FDA’s findings — a response consistent with the company’s decades-long pattern of denial and deflection documented in internal memos.

Asbestos: A Known Carcinogen with No Safe Level

Asbestos is classified as a Group 1 carcinogen by the International Agency for Research on Cancer — the highest classification, meaning there is sufficient evidence that it causes cancer in humans. There is no known safe level of asbestos exposure. Even trace amounts of asbestos fibers, when inhaled or ingested, can cause mesothelioma, lung cancer, and other cancers decades later. The latency period for asbestos-related diseases is typically 20 to 50 years.

The presence of asbestos in a consumer product marketed for daily application to the most intimate areas of the body — including application to infants — represents one of the most egregious product safety failures in American consumer product history. Every time a consumer opened a bottle of contaminated Baby Powder, they potentially inhaled microscopic asbestos fibers. Every perineal application potentially delivered asbestos fibers to internal tissues. J&J’s knowledge of this contamination, documented in its own internal records, transforms this from a product defect case into a case of corporate recklessness.

Research & evidence

Scientific Evidence

meta-analysis

IARC Monograph Volume 136: Talc and Acrylonitrile

International Agency for Research on Cancer Working Group. (2024). IARC Monographs on the Identification of Carcinogenic Hazards to Humans

Key findings

  • Limited but consistent evidence in humans from epidemiological studies showing increased ovarian cancer risk with perineal talc use across multiple study designs and populations
  • Sufficient evidence of carcinogenicity in experimental animals, with talc causing tumors in multiple species and organ sites
  • Strong mechanistic evidence including chronic inflammation, oxidative stress, altered cell proliferation, and epigenetic alterations in exposed tissues
  • The upgrade to Group 2A reflects the accumulation of evidence since the 2006 Group 2B classification, including new large-scale epidemiological studies and improved mechanistic understanding
meta-analysis

Prospective Cohort Studies of Talc Use and Ovarian Cancer Risk

Harvard Nurses’ Health Study / Women’s Health Initiative Investigators. (2020). Journal of the National Cancer Institute / Journal of Clinical Oncology

Key findings

  • Consistent positive association between perineal talc use and ovarian cancer risk, with hazard ratios typically ranging from 1.20 to 1.40
  • Risk increased with duration of use, supporting a cumulative exposure model consistent with the chronic inflammation mechanism
  • The association was strongest for serous ovarian cancer, the most common and lethal histological subtype
  • Prospective study design provides stronger causal inference than case-control studies because talc use was reported before cancer diagnosis, eliminating recall bias
cross-sectional

Perineal Talc Use and Ovarian Cancer Risk: A Case-Control Study

Cramer DW, Welch WR, Scully RE, Wojciechowski CA. (1982). The Lancet

Key findings

  • Women who used talcum powder for perineal hygiene had an odds ratio of 1.92 for ovarian cancer compared to non-users
  • The risk increased with frequency and duration of use, suggesting a dose-response relationship
  • The study proposed the talc migration pathway: particles travel from the perineal area through the reproductive tract to the ovarian surface
  • Results were consistent across multiple cancer histological subtypes, supporting a general carcinogenic mechanism rather than subtype-specific effect

FAQ

Frequently Asked Questions

36 QUESTIONS

Yes. More than 63,000 lawsuits have been filed against Johnson & Johnson alleging that Baby Powder and other talc-based products caused ovarian cancer and mesothelioma. You may have a legal claim if you used J&J talcum powder products and were subsequently diagnosed with ovarian cancer, mesothelioma, fallopian tube cancer, peritoneal cancer, or endometrial cancer. The strongest claims involve long-term perineal use with a documented cancer diagnosis. Attorneys handle these cases on contingency. Fee arrangements vary, so confirm terms with any attorney you consult. The MDL 2738 in the District of New Jersey is actively coordinating thousands of federal cases, and state court proceedings continue nationwide.

Dive deeper

Related Guides

7 GUIDES

The full investigation

Part of the Talcum Powder Investigation